CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S23, 2014 Special supplement with the abstract book of LATINFARMA 2013 Oral Communication CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011 Morejón M, Tirado J, Jiménez A, Mulen M. Hospital Universitario “Cmdte. Manuel Fajardo”, Zapata y D, Vedado, La Habana, … Continue reading CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011

J Pharm Pharmacogn Res 2(Suppl. 1): S23, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 042: IMPACT OF AN ANTIBIOTIC POLICY ON ANTIMICROBIAL CONSUMPTION AT COMANDANTE MANUEL FAJARDO UNIVERSITY HOSPITAL, 2011

Morejón M, Tirado J, Jiménez A, Mulen M.

Hospital Universitario “Cmdte. Manuel Fajardo”, Zapata y D, Vedado, La Habana, Cuba. E-mail: moisesm@infomed.sld.cu
Abstract

Introduction: At present, it is unanimous among scientists that the use of antibiotics, specifically their misuse, is the most significant factor in the emergence and development of bacterial resistance. Today, over 50% of hospitalized patients receive antibiotics; it is considered that 25-50% is unnecessary. This has concerned all levels. That is why; the WHO issued a document in 2001: "Strategies to contain antimicrobial resistance," which states in its first page that the main cause of bacterial resistance is the inappropriate use of antimicrobials. Therefore, one of its recommendations calls for the creation of antibiotic policies and monitoring their consumption in all health institutions.

Objectives: To determine how the patterns of antimicrobial prescriptions vary with the application of an antibiotic policy.

Results: There was a variation of consumption in the cephalosporin family, which was further used; cefuroxime was the highest consumed, three times more than ceftriaxone, whereas cefazolin was only used in surgical prophylaxis, and cefepime was only used in the intensive care units. meropenem and piperazicillina/tazolbactam were only used on serious case in the care units.

Conclusions: The patterns of prescription of antimicrobial drugs met favorably the recommended guidelines for the policy of antibiotics use, which could promote a more rational use of them.

Piceatannol-rich extract from Passiflora edulis and hyperpigmentation
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 900-910, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1717_12.5.900 Original Article Piceatannol-rich extract from Passiflora edulis Sims seeds attenuates morphological differentiation through the reduction of MITF mRNA expression and F-actin polymerization in UVB-induced hyperpigmented B16F10 cells [El extracto rico en piceatannol de las semillas de Passiflora edulis Sims atenúa la … Continue reading Piceatannol-rich extract from Passiflora edulis and hyperpigmentation
Immunostimulatory effect of a nature-derived capsule
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 892-899, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1751_12.5.892 Original Article Potential effects of Linh Loc Son hard capsule – a Vietnamese herbal combination in immunodeficiency induced by cyclophosphamide on mice [Efectos potenciales de la cápsula dura Linh Loc Son, una combinación de hierbas vietnamitas en la inmunodeficiencia inducida por … Continue reading Immunostimulatory effect of a nature-derived capsule
Epidermal growth factor receptor mutant inhibitors as NSCLC drugs
J. Pharm. Pharmacogn. Res., vol. 12, no. 5, pp. 881-891, Sep-Oct 2024. DOI: https://doi.org/10.56499/jppres23.1740_12.5.881 Original Article Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs [Inhibidor del receptor del factor de crecimiento epidérmico mutante T790M-L858R-V948R de la hoja de Calophyllum inophyllum L. como posible fármaco … Continue reading Epidermal growth factor receptor mutant inhibitors as NSCLC drugs

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio